Navigation Links
Sigma-Aldrich Signs Agreement With SouthWest NanoTechnologies to Distribute SWeNT(R) Single-Wall Carbon Nanotubes
Date:12/3/2008

ST. LOUIS, Dec. 3 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) and SouthWest NanoTechnologies Inc. (SWeNT), a leading producer of single-wall carbon nanotubes, announced today that they have signed an agreement under which Sigma-Aldrich will distribute SWeNT's single-wall carbon nanotubes to the research and development community.

Under the terms of the agreement, Sigma-Aldrich will exclusively distribute research quantities of SWeNT(R) CG 100, SWeNT(R) SG 65 and SWeNT(R) SG 76 single-wall nanotubes globally through its Aldrich(R) division (http://www.sigma-aldrich.com/nanocarbon). SWeNT will continue to work closely with industry partners to deliver commercial quantities of the materials and focus on commercial application development and large-scale production.

Single-wall carbon nanotubes consist of a hollow cylinder of carbon with a diameter equal to approximately one nanometer -- a billionth of a meter. Due to their unusual structure, single-wall nanotubes exhibit extraordinary optical and electronic properties, tremendous strength and flexibility, and high thermal and chemical stability. These remarkable properties make them suitable for a wide range of applications in the automotive, aeronautics, electronics, displays, energy and healthcare markets.

"There are significant global market opportunities for single-wall carbon nanotubes, and Sigma-Aldrich has a world-class distribution network. This agreement will provide the best possible products and service to the research and development community, which is incorporating SWeNT carbon nanotubes into innovative, emerging technologies," said SWeNT CEO David Arthur. "In our role as a leading producer of high-quality single-wall nanotubes, we are committed to being an innovative partner in Sigma-Aldrich's continued development and creative applications. This agreement is key to reaching that goal."

Ilya Koltover, business development manager, Aldrich Chemistry and Materials Science, added: "Progress in nanotechnology research depends on a reliable supply of consistently high-quality nanomaterials, supported by thorough characterization and technical information. This is especially true for single wall carbon nanotubes, and we are pleased to work with SWeNT, who is committed to the goal of providing such supply. This partnership will help researchers and accelerate nanotechnology innovation around the world."

For more information about the single-wall carbon nanotubes, visit http://www.sigma-aldrich.com/nanocarbon.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. Sigma-Aldrich has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use our products. The Company operates in 36 countries and has 8,000 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning website at http://www.sigma-aldrich.com.

About SouthWest NanoTechnologies: SWeNT produces three lines of carbon nanotube products using the patented CoMoCAT(R) catalytic method, widely recognized for its quality and scalability. The Company was founded in 2001 to commercialize nanotube technology developed at the University of Oklahoma by Daniel Resasco, a professor of chemical engineering and world-renowned expert in the fields of single-wall carbon nanotubes and catalysis. In June 2008, SWeNT moved to its new $3.9 million, 18,000-square-foot manufacturing facility in Norman. With approximately 10,000 square feet of 32-foot high-bay production space, SWeNT can produce at least 100 times more product than at its previous pilot plant location. For more information about SWeNT, visit http://www.swentnano.com.

Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Companies' expectations, goals, beliefs, intentions and the like, which involve assumptions regarding the Companies' operations and conditions in the markets the Companies serve. The Companies do not undertake any obligation to update these forward-looking statements.

Sigma-Aldrich and Aldrich are trademarks of Sigma-Aldrich Biotechnology LP and Sigma-Aldrich Co.

SWeNT(R) and CoMoCAT(R) are registered trademarks of SouthWest NanoTechnologies Inc.


'/>"/>
SOURCE Sigma-Aldrich
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
2. Sigma-Aldrich and Lab Manager Magazine Present Webinar On Laboratory Environmental, Health and Safety Compliance Strategies
3. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
4. Sigma-Aldrich and Ingenuity Systems Announce Partnership to Create E-Commerce Search Solution Based on Biological Knowledge
5. Sigma-Aldrich to Present at the UBS 2007 Global Life Sciences Conference on September 25, 2007
6. Sigma-Aldrich Names Patrick Sullivan New VP of Research and Development for Research Biotech
7. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
8. Sigma-Aldrich Corporations 3rd Quarter 2007 Earnings Conference Call
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. Sigma-Aldrich (Nasdaq: SIAL) Q3 2007 Sales Increase 14.0%, Yielding Diluted EPS of $.54.
11. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... , Feb. 17, 2017  Protagonist Therapeutics, ... data on its oral peptide drug candidates, PTG-100 ... of the European Crohn,s and Colitis Organization (ECCO).  ... Barcelona, Spain from February 15 ... detail preclinical data on Protagonist drug candidates PTG-100 ...
(Date:2/16/2017)... Arbor, MI (PRWEB) , ... February 16, 2017 , ... ... 5:00-7:00 p.m. The event will be held at Avomeen Analytical Services (4840 Venture ... by a MichBio member organization. They provide an opportunity to interact with peers, make ...
(Date:2/16/2017)... and GREENWICH, Conn. , ... investment firm focused on venture growth investments in ... of Josh Richardson , M.D. to Managing ... in biotechnology companies.  He is a board observer ... roles in Longitude,s investments in Aimmune Therapeutics, Akebia ...
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
Breaking Biology Technology:
(Date:2/2/2017)...  Central to its deep commitment to honor ... Japan Prize Foundation today announced the laureates of ... envelope in their respective fields of Life Sciences ... being recognized with the 2017 Japan Prize for ... to the advancement of science and technology, but ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... CITY , Jan. 26, 2017  Crossmatch, a ... unveiled a new solution aimed at combatting fraud, waste ... solution was introduced at the Action on Disaster Relief ... key meeting point for UN agencies and foreign assistance ... Fraud, waste and abuse are a largely unacknowledged ...
Breaking Biology News(10 mins):